Seeking Alpha1d
IPA ImmunoPrecise Antibodies Ltd.
The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.
The Globe and Mail15d
ImmunoPrecise Antibodies (IPA) Announces Completion of At-the-Market Equity Offering and Full Conversion of Yorkville Debenture
ImmunoPrecise Antibodies Ltd. (“IPA” or the “Company”) (NASDAQ: IPA), a leader in AI-driven antibody discovery and development, today announced the successful completion of its previously ...
News Channel Nebraska16d
ImmunoPrecise Antibodies (IPA) Announces Completion of At-the-Market Equity Offering and Full Conversion of Yorkville Debenture
ImmunoPrecise Antibodies Ltd. (“IPA” or the “Company”) (NASDAQ: IPA), a leader in AI-driven antibody discovery and development, today announced the successful completion of its previously disclosed ...
Nasdaq16d
ImmunoPrecise Antibodies (IPA) Announces Completion of At-the-Market Equity Offering and Full Conversion of Yorkville Debenture
AUSTIN, Texas--(BUSINESS WIRE)-- ImmunoPrecise Antibodies Ltd. (“IPA” or the “Company”) (NASDAQ: IPA), a leader in AI-driven antibody discovery and ...
Yahoo Finance16d
ImmunoPrecise Antibodies (IPA) Announces Completion of At-the-Market Equity Offering and Full Conversion of Yorkville Debenture
AUSTIN, Texas, January 27, 2025--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. ("IPA" or the "Company") (NASDAQ: IPA), a leader in AI-driven antibody discovery and ...
Yahoo Finance16d
ImmunoPrecise Antibodies (IPA) Announces Completion of At-the-Market Equity Offering and Full Conversion of Yorkville Debenture
AUSTIN, Texas, January 27, 2025--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. ("IPA" or the "Company") (NASDAQ: IPA), a leader in AI-driven antibody discovery and development, today announced the ...